U.S. flag

An official website of the United States government

NM_000518.5(HBB):c.16C>T (p.Pro6Ser) AND not specified

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Jun 17, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002271370.8

Allele description [Variation Report for NM_000518.5(HBB):c.16C>T (p.Pro6Ser)]

NM_000518.5(HBB):c.16C>T (p.Pro6Ser)

Genes:
LOC106099062:HBB recombination region [Gene]
HBB:hemoglobin subunit beta [Gene - OMIM - HGNC]
LOC107133510:origin of replication at HBB [Gene]
Variant type:
single nucleotide variant
Cytogenetic location:
11p15.4
Genomic location:
Preferred name:
NM_000518.5(HBB):c.16C>T (p.Pro6Ser)
Other names:
P5S; Hb Tyne
HGVS:
  • NC_000011.10:g.5227006G>A
  • NG_000007.3:g.70610C>T
  • NG_042296.1:g.537G>A
  • NG_046672.1:g.4941G>A
  • NG_059281.1:g.5066C>T
  • NM_000518.5:c.16C>TMANE SELECT
  • NP_000509.1:p.Pro6Ser
  • LRG_1232t1:c.16C>T
  • LRG_1232:g.5066C>T
  • LRG_1232p1:p.Pro6Ser
  • NC_000011.9:g.5248236G>A
  • NM_000518.4:c.16C>T
Protein change:
P6S; PRO5SER
Links:
HBVAR: 225; OMIM: 141900.0451; dbSNP: rs33912272
NCBI 1000 Genomes Browser:
rs33912272
Molecular consequence:
  • NM_000518.5:c.16C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002555968Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Uncertain significance
(Jun 17, 2022)
germlineclinical testing

PubMed (6)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

A new beta chain variant, Hb Tyne [beta 5(A2)Pro-->Ser].

Langdown JV, Williamson D, Beresford CH, Gibb I, Taylor R, Deacon-Smith R.

Hemoglobin. 1994 Sep;18(4-5):333-6. No abstract available.

PubMed [citation]
PMID:
7852088

Regional heterogeneity of beta-thalassemia mutations in the multi ethnic Indian population.

Colah R, Gorakshakar A, Nadkarni A, Phanasgaonkar S, Surve R, Sawant P, Mohanty D, Ghosh K.

Blood Cells Mol Dis. 2009 May-Jun;42(3):241-6. doi: 10.1016/j.bcmd.2008.12.006. Epub 2009 Feb 28.

PubMed [citation]
PMID:
19254853
See all PubMed Citations (6)

Details of each submission

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV002555968.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (6)

Description

Variant summary: HBB c.16C>T (p.Pro6Ser) results in a non-conservative amino acid change located in the Globin domain (IPR000971) of the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 4e-06 in 251132 control chromosomes (gnomAD). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.16C>T has been reported in the literature in at least one compound heterozygous individual affected with Hemoglobinopathy (Kayisli_2005). The variant was also reported in a severely anemic patient with a truncating variant in cis and a pathogenic splice variant in trans (Agarwal_1997). These data do not allow any conclusion about variant significance. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Three ClinVar submitters have assessed the variant since 2014: all classified the variant as of uncertain significance. Based on the evidence outlined above, the variant was classified as uncertain significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 3, 2024